about
Aspirin prevents adhesion of T lymphoblasts to vascular smooth muscle cellsA polymorphism regulates CYP4A11 transcriptional activity and is associated with hypertension in a Japanese populationANRIL: molecular mechanisms and implications in human healthAkt activation prevents Apop-1-induced death of cellsApop-1, a novel protein inducing cyclophilin D-dependent but Bax/Bak-related channel-independent apoptosisE-cadherin and claudin-4 expression has circadian rhythm in adult rat kidneyThe counterregulating role of ACE2 and ACE2-mediated angiotensin 1-7 signaling against angiotensin II stimulation in vascular cellsAzilsartan Improves Salt Sensitivity by Modulating the Proximal Tubular Na+-H+ Exchanger-3 in MiceGenome-wide association study of coronary artery disease in the JapaneseIdentification of evidence suggestive of an association with peripheral arterial disease at the OSBPL10 locus by genome-wide investigation in the Japanese population.Prevalence of frailty in Japan: A systematic review and meta-analysis.Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsModified forelimb grip strength test detects aging-associated physiological decline in skeletal muscle function in male mice.Ubiquitin carboxyl-terminal hydrolase L1, a novel deubiquitinating enzyme in the vasculature, attenuates NF-kappaB activation.Atypical hemolytic uremic syndrome with MCP mutations preceded by respiratory infection.Effect of azilsartan versus candesartan on morning blood pressure surges in Japanese patients with essential hypertensionHepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice.Comparison of the antialbuminuric effects of benidipine and hydrochlorothiazide in Renin-Angiotensin System (RAS) inhibitor-treated hypertensive patients with albuminuria: the COSMO-CKD (COmbination Strategy on Renal Function of Benidipine or DiuretDiabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetesFibroblast growth factor 23 and 25-hydroxyvitamin D levels are associated with estimated glomerular filtration rate decline.Microarray analysis of tonsils in immunoglobulin A nephropathy patients.Combinations of olmesartan and a calcium channel blocker or a diuretic in elderly hypertensive patients: a randomized, controlled trial.Promoter Polymorphism of RGS2 Gene Is Associated with Change of Blood Pressure in Subjects with Antihypertensive Treatment: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes Study.Autophagic clearance of mitochondria in the kidney copes with metabolic acidosis.Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort.Malt1-induced cleavage of regnase-1 in CD4(+) helper T cells regulates immune activation.Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals.Fetuin-mineral complex reflects extraosseous calcification stress in CKDDifferential regulation of amyloid precursor protein/presenilin 1 interaction during Aβ40/42 [corrected] production detected using fusion constructs.Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation.Vascular signaling pathways in the metabolic syndrome.Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse model.Non-invasive magnetic resonance imaging in rats for prediction of the fate of grafted kidneys from cardiac death donors.Clinical efficacy of a new angiotensin II type 1 receptor blocker, pratosartan, in hypertensive patients.Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population.Autophagy protects the proximal tubule from degeneration and acute ischemic injury.Combination therapy of hypertension in the elderly: a subgroup analysis of the Combination of OLMesartan and a calcium channel blocker or diuretic in Japanese elderly hypertensive patients trialHigh prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study.Comparison of olmesartan combined with a calcium channel blocker or a diuretic in elderly hypertensive patients (COLM Study): safety and tolerability.
P50
Q28217990-D81D4216-44B7-4A09-AB91-79AD259C4977Q28297988-DDE47900-B47B-4A06-AD3E-828B1B7DD609Q28394102-3AFE692D-6931-4DFB-91F0-E5AFA13CC643Q28505409-15D566A2-D86B-4235-BF7F-4293DD6C21B0Q28506730-AA170536-78CA-4097-AA4A-D23B31C1E7BEQ28570101-7903BF59-5FFC-47EC-841E-B5CDF4F8F7A1Q28575682-5AC34935-0DBB-4FA6-8DE7-14EDAB0D48CAQ28602057-719EB730-0D8D-4096-8B66-2D29D79F1F4DQ28943353-CE85EFB1-8286-42E5-98FD-EFEFB5794A73Q29417114-2645DF11-EE18-4855-AEE1-474475632183Q30238694-12706221-1676-45B3-AFB7-6C283AF39872Q30814231-90BB67DA-FC5A-4D7F-A5FF-FA49D5618ABBQ30837885-28666EC9-1EF6-43F7-97D5-266C0368A51BQ33293798-9D59A5AD-A8D7-4D8E-A01E-97CDB8CD1072Q33441892-702071CF-36EE-4B93-B85B-0DC86DC6FFB7Q33572451-6E90B7F4-6FBA-43B7-BB45-557930C2D164Q33669422-91F15DE5-7ECE-4DEE-BAB1-DCD69433244BQ33843864-98622203-4868-4193-AC19-6AFBFA00BA96Q33859600-DF788C53-06E2-4EFF-B9B4-2ED62B2D22E9Q33873450-92A990CD-BD49-4EB6-A679-CE6EA005CF32Q34097353-B187208B-EBC5-400C-BA2D-ED65FB2ADFB9Q34196851-B7E09732-5C53-43CD-8A40-3584CDF5BB7FQ34218218-3811A68F-41A8-4115-8FA5-DE553584DD57Q34260052-586A9AE9-FA96-4414-BACA-DCD76B660F74Q34281450-7FD6C432-EC8A-467B-B668-324E750CBC06Q34346617-B735D24D-6E9B-47A4-B61B-48CA2AFE0033Q34438809-82D0DCCC-145D-4509-9429-C51522610FD8Q34457107-76D192DB-4604-4C35-8E1A-7CACBA0BBE3FQ34477370-C154B3E9-1C4C-4045-9F74-866E686E2EF7Q34495057-45FB4442-A0EF-4F1A-9362-17CC5028FDF4Q34555130-D6D21A76-788C-4CBC-8DD5-87C270C3AB82Q34659914-C2898035-6A90-4670-9C98-F26C9A815B7CQ34718286-786E09C9-2102-43E8-AC56-CE18B3AC3636Q34764169-0AF5E2C6-A4D4-4305-AC85-7DE5D4D6D4D1Q34784711-F1A62442-42E1-4335-8AFD-BD573C86608DQ34810969-97C6F94B-46EC-4E42-BFD4-D3463AE708ADQ34870792-05EF0FF5-4894-4C78-A184-D2B3158616BBQ34876994-AA889C3A-8959-44E5-B73A-3BEE8D61D033Q34927284-F04970E9-1145-4AA1-8A73-8D3BA5D19A47Q35065309-F7DA9CB7-443D-450D-A0C9-C815DBB24685
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hiromi Rakugi
@ast
Hiromi Rakugi
@en
Hiromi Rakugi
@es
Hiromi Rakugi
@nl
Hiromi Rakugi
@sl
type
label
Hiromi Rakugi
@ast
Hiromi Rakugi
@en
Hiromi Rakugi
@es
Hiromi Rakugi
@nl
Hiromi Rakugi
@sl
prefLabel
Hiromi Rakugi
@ast
Hiromi Rakugi
@en
Hiromi Rakugi
@es
Hiromi Rakugi
@nl
Hiromi Rakugi
@sl
P106
P1153
57202699453
P31
P496
0000-0001-6508-4338
P569
2000-01-01T00:00:00Z